Measuring vital signs in children is harder than it sounds. Adults will sit still, extend an arm, and breathe normally on command. A three-year-old will do none of those things. A seven-year-old might cooperate for about 45 seconds before deciding the pulse oximeter clip is a toy. And a teenager in the emergency department would rather be anywhere else, which tends to show up as an elevated heart rate that may or may not reflect actual clinical status.
This isn't a minor inconvenience. Abnormal vital signs in children are among the strongest predictors of serious illness and hospital admission. A 2017 analysis in the European Journal of Emergency Medicine found that initial vital signs taken in the pediatric emergency department are frequently skewed by anxiety and irritability, leading to unrealistic triage levels (Zachariasse et al., 2017). The measurement itself — a stranger attaching unfamiliar equipment to a frightened child — contaminates the data it's supposed to collect.
Camera-based contactless monitoring offers a way around this problem. Record a child's face for 30 to 60 seconds with a standard camera, run the video through rPPG algorithms, and extract heart rate without touching the patient at all. No clips, no cuffs, no wires, no meltdown.
"rPPG potentially ameliorates problems like fretfulness and fragile skin contact associated with conventional probes in children." — Chua et al., Annals of Translational Medicine (2024)
Where pediatric rPPG research actually stands
The honest answer is: behind adult research by several years. Remote photoplethysmography has been validated extensively in adults since the mid-2000s, but pediatric studies are still catching up. Children aren't small adults — their physiology, behavior, and anatomy create distinct challenges for camera-based systems.
The most thorough pediatric rPPG study published to date comes from Chua et al. (2024) at KK Women's and Children's Hospital in Singapore. Their two-phased prospective study, published in Annals of Translational Medicine, recruited 10 neonates and 28 children aged 5 to 16 years in Phase 1, generating 765 data points. Phase 2 focused on 23 patients aged 12 to 16, producing 559 data points.
The results were mixed in a telling way. For adolescents aged 12 to 16, heart rate readings from rPPG correlated strongly with pulse oximetry (Spearman's Rs = 0.82, 95% CI: 0.78–0.85). But for children under 10, the readings were clinically discrepant — not close enough to trust. Respiratory rate and SpO2 showed weak correlation across all ages.
What this tells us: the technology works when the subject sits relatively still and has enough exposed facial skin area for the camera to pick up blood volume changes. Older children meet those conditions. Younger children — who fidget, cry, turn away, and have smaller faces — don't, at least not with current algorithms.
Comparing pediatric vital sign monitoring approaches
| Method | Contact Required | Child Distress Level | Heart Rate Accuracy (Children) | Respiratory Rate Accuracy | SpO2 Accuracy | Home Use Potential | Age Range Validated |
|---|---|---|---|---|---|---|---|
| Standard pulse oximetry | Yes — finger clip | Moderate — often resisted | Gold standard | N/A (separate count) | Gold standard | Limited — needs device | All ages |
| Manual counting | Yes — stethoscope/observation | Low to moderate | Operator dependent | Operator dependent | N/A | Not practical | All ages |
| Wearable patches | Yes — adhesive | Low to moderate | ±2-4 bpm | ±2-5 brpm | Limited data | Possible | Limited pediatric data |
| rPPG camera (ages 12-16) | None | Low | Rs = 0.82 vs standard | Weak correlation | Weak correlation | High — smartphone camera | 12-16 years validated |
| rPPG camera (ages < 10) | None | Low | Clinically discrepant | Weak correlation | Weak correlation | High — if algorithms improve | Not yet validated |
| Smartphone app (Lifelight) | None — front camera | Low | In development | In development | In development | High — consumer device | Trial: 0-17 years |
Sources: Chua et al. (2024), Misra et al. (2025), Zachariasse et al. (2017).
The table makes the challenge visible. Contact-based methods work across all ages but cause distress. Contactless methods avoid distress but haven't proven reliable for younger children yet. The technology gap for patients under 12 is the central problem the field needs to solve.
The Lifelight VISION-Junior trial
The largest dedicated pediatric contactless vital signs study currently underway is VISION-Junior, run by Misra et al. (2025) at Sunderland Royal Hospital in the United Kingdom. The study protocol, published in JMIR Research Protocols, describes a clinical trial designed to develop and validate the Lifelight smartphone app for measuring pulse rate, respiratory rate, and oxygen saturation in children.
The trial recruited 532 pediatric patients (ages 0 to 17) attending the pediatric emergency department, exceeding its original 500-patient target. Recruitment ran from June 2023 to April 2024. The study collected high-resolution face and torso video — torso recording was added for children under 5, recognizing that chest movement may be a more reliable respiratory signal than facial cues in very young patients.
What makes this trial significant beyond its size is the deliberate focus on diversity. The protocol specifies recruitment targets by age, sex, and skin tone using the Fitzpatrick 6-point scale. Most rPPG validation studies have been conducted on predominantly light-skinned populations, and melanin affects how the signal presents. If you want algorithms that work for all children, you need a training dataset that actually looks like all children.
The Lifelight app has already received Class I CE marking for adult use in the UK based on the earlier VISION-D and VISION-V adult studies. The pediatric extension represents a logical but technically demanding next step — children's physiology differs enough from adults that the adult algorithms can't simply be applied downward.
Clinical applications in pediatric settings
Emergency department triage
Pediatric emergency departments face a specific problem: children arrive anxious, and anxiety elevates heart rate and respiratory rate. Standard triage systems like the Pediatric Early Warning Score rely on vital sign thresholds that were established under calmer conditions. A child whose heart rate reads 140 bpm might be genuinely tachycardic — or might just be scared of the blood pressure cuff.
Contactless monitoring could capture vital signs before the child realizes they're being assessed. A camera in the waiting room or triage area, recording passively, could generate baseline readings that aren't contaminated by the measurement process itself. Zachariasse et al. (2017) specifically identified this anxiety artifact as a source of over-triage in pediatric emergency departments.
Telemedicine and home monitoring
The COVID-19 pandemic accelerated telemedicine adoption across pediatric care, but remote consultations have a gap: clinicians can see the child on video but can't measure vital signs through the screen. A camera-based system running on the parent's smartphone would close that gap.
For chronically ill children — those with asthma, congenital heart conditions, cystic fibrosis, or immunocompromising conditions — regular vital sign monitoring at home could catch early signs of deterioration before symptoms become obvious. Misra et al. (2025) specifically framed the Lifelight pediatric development around this use case, noting that currently available methods are not suitable for regular VS measurement in the home or community setting.
Reducing procedural distress
Children undergoing medical procedures often need continuous monitoring, and the monitoring setup itself adds to their stress. In pediatric anesthesia, a 2023 review in the journal Paediatric Anaesthesia outlined the challenges and potential of non-contact monitoring during procedures, noting that eliminating physical sensor attachment could meaningfully reduce pre-procedural anxiety. For children with autism spectrum disorder or sensory processing differences, the benefit is even more pronounced — tactile medical devices can trigger significant distress responses that complicate care delivery.
Current research and evidence gaps
The pediatric rPPG field has a few core problems to solve before clinical deployment becomes realistic.
Age-dependent accuracy remains the biggest barrier. The Chua et al. (2024) study showed a clear divide: rPPG works reasonably well for adolescents but not for younger children. The reasons are partly physiological (smaller blood vessels, different skin thickness, higher baseline heart rates) and partly behavioral (movement, crying, looking away from the camera). Algorithms trained predominantly on adult data don't generalize well to pediatric populations.
Respiratory rate measurement lags behind heart rate across all ages. Heart rate can be extracted from subtle skin color changes, but respiratory rate requires detecting chest or abdominal movement — which is harder to isolate in a child who is simultaneously fidgeting, talking, and squirming. The VISION-Junior approach of recording the torso separately for younger children acknowledges this challenge directly.
SpO2 remains unproven in pediatric camera-based systems. Oxygen saturation estimation via rPPG requires multi-wavelength analysis and is more sensitive to skin tone, ambient lighting, and motion artifacts than heart rate extraction. Neither the Chua et al. (2024) nor the VISION-Junior study has demonstrated reliable pediatric SpO2 from camera alone.
Regulatory pathways are undefined for pediatric contactless monitoring. The FDA and European regulatory bodies have not established clear frameworks for validating camera-based vital sign measurement in children. This creates uncertainty for developers and means that even systems showing strong research results face an unclear path to clinical deployment.
What pediatric contactless monitoring looks like in five years
The direction is fairly clear, even if the timeline isn't. Algorithm development for younger age groups will accelerate as studies like VISION-Junior produce large, diverse training datasets. Heart rate measurement for adolescents is already close to clinically useful; extending that down to school-age children (6-12) is the most achievable near-term goal. Getting reliable readings from toddlers and infants will take longer — their movement patterns and smaller physiology make the signal extraction problem fundamentally harder.
Smartphone-based deployment is the likely delivery mechanism. Purpose-built camera hardware adds cost and complexity, while every parent already carries a device with a camera capable of recording at sufficient quality for rPPG. The Lifelight app model — standard smartphone, no additional hardware, vital signs in 30 to 60 seconds — is the form factor that makes sense for pediatric telemedicine and home monitoring.
Circadify has developed contactless vital sign measurement technology using rPPG and is working to bring these capabilities across clinical settings, including pediatric care. The company's camera-based platform is built to extract heart rate, respiratory rate, and other physiological signals without physical contact — an approach that addresses the specific challenges of monitoring children who don't tolerate conventional sensors well.
Frequently Asked Questions
Can rPPG accurately measure a child's heart rate?
For older children aged 12 to 16, research shows strong correlation between rPPG-derived heart rate and standard pulse oximetry, with Spearman's correlation coefficients reaching 0.82. For younger children under 10, accuracy drops significantly, and algorithms still need refinement to account for smaller facial features, more frequent movement, and different skin characteristics.
Why is contactless monitoring useful for pediatric patients?
Children often become anxious and distressed when conventional monitoring equipment is attached, which can distort vital sign readings and make clinical assessment harder. Contactless systems eliminate physical contact entirely, reducing patient stress and enabling more representative baseline readings. This is especially relevant for children with sensory sensitivities or skin conditions.
Is camera-based pediatric vital sign monitoring available for clinical use?
Not yet. Several systems are in clinical trials, including the Lifelight app which completed recruitment of 532 pediatric patients in 2024 and is refining its algorithms. No camera-based system has received regulatory clearance specifically for pediatric vital sign measurement, though adult-validated systems exist.
What vital signs can cameras measure in children?
Current research has demonstrated heart rate measurement with reasonable accuracy in older children. Respiratory rate and oxygen saturation measurement remain less reliable across all pediatric age groups. The VISION-Junior study is actively working to develop algorithms for pulse rate, respiratory rate, and SpO2 across the full pediatric age range.